Catherine Alix-Panabières, PhD, Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB, Hôpital Saint-Eloi - CHRU Montpellier, France
Emmanuel Antonarakis, MD, Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA
Massimo Cristofanilli, MD, FACP, Chief, Breast Medical Oncology, Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team, Weill Cornell Medicine/New York-Presbyterian Hospital, Department of Medicine, Division of Hematology-Oncology, NY, USA
Caroline Dive, PhD, Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK
Helen Heitzer, PhD, Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Dave Hoon, PhD, Director Translational Molecular Medicine, SJCI PHS, Santa Monica CA, USA
Sabine Kasimir-Bauer, PhD, Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany
Evi Lianidou, PhD, Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece
Klaus Pantel, MD, PhD, Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Nicholas Papadopoulos, PhD, Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
Jean-Yves Pierga, MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France
Michael Speicher, MD, PhD, Institute of Human Genetics, Medical University of Graz, Austria
Nikolas Stoecklein, MD, Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany
Leon Terstappen, MD, PhD, Professor, Faculty of Science and Technology, TechMed Centre, Department of Medical Cell BioPhysics, University of Twente, the Netherlandss
Emmanuel Antonarakis, MD, Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA
Massimo Cristofanilli, MD, FACP, Chief, Breast Medical Oncology, Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team, Weill Cornell Medicine/New York-Presbyterian Hospital, Department of Medicine, Division of Hematology-Oncology, NY, USA
Caroline Dive, PhD, Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK
Helen Heitzer, PhD, Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
Dave Hoon, PhD, Director Translational Molecular Medicine, SJCI PHS, Santa Monica CA, USA
Sabine Kasimir-Bauer, PhD, Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany
Evi Lianidou, PhD, Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece
Klaus Pantel, MD, PhD, Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany
Nicholas Papadopoulos, PhD, Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
Jean-Yves Pierga, MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France
Michael Speicher, MD, PhD, Institute of Human Genetics, Medical University of Graz, Austria
Nikolas Stoecklein, MD, Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany
Leon Terstappen, MD, PhD, Professor, Faculty of Science and Technology, TechMed Centre, Department of Medical Cell BioPhysics, University of Twente, the Netherlandss
